About Nathalie Bofarull

This author has not yet filled in any details.
So far Nathalie Bofarull has created 2 blog entries.

TransBioLine attended the closing meeting of eTRANSAFE

2023-03-08T14:50:05+00:00March 7th, 2023|Latest News|

On the 23rd of February, Sophia Samodelov, TransBioLine Project coordinator, participated in the closing meeting of eTRANSAFE Project “Towards a Quantum leap in drug safety assessment”. eTRANSAFE (enhancing translational safety assessment through integrative knowledge management) [...]

New publication from University of Nottingham

2023-02-02T10:48:20+00:00February 2nd, 2023|Latest News, Publications|

  Millions of people with rheumatoid arthritis and psoriasis could benefit from Nottingham biomarker research. Nottingham researchers found its side effects are less likely than previously thought and are calling for guidelines affecting the use of [...]

imitransbioline IMI2_TransBioLine @imitransbioline ·
19 Apr

Progresses in miRNA identification as reliable safety DILI #biomarkers were presented during last @BritToxSoc meeting.

Big advances in liquid biopsy are foreseen!
#IHICarryTheTorch #H2020 #EUHealthResearch @IHIEurope

Reply on Twitter 1781285285566791683 Retweet on Twitter 1781285285566791683 1 Like on Twitter 1781285285566791683 2 Twitter 1781285285566791683
Load More
ACKNOWLEDGEMENT

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 821283. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA companies.

IMI Europa
info@transbioline.com
© Copyright    |   TransBioLine   |   Disclaimer: The TransBioLine website reflects the author’s view and that neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein.
Twitter
This website uses cookies and third party services. Ok
Go to Top